Wealthcare Advisory Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.41M Sell
3,162
-29
-0.9% -$12.9K 0.03% 409
2025
Q1
$1.55M Sell
3,191
-70
-2% -$33.9K 0.04% 350
2024
Q4
$1.31M Buy
3,261
+172
+6% +$69.3K 0.04% 365
2024
Q3
$1.44M Sell
3,089
-239
-7% -$111K 0.04% 332
2024
Q2
$1.56M Buy
3,328
+110
+3% +$51.6K 0.05% 285
2024
Q1
$1.35M Buy
3,218
+141
+5% +$58.9K 0.04% 304
2023
Q4
$1.25M Sell
3,077
-41
-1% -$16.7K 0.05% 271
2023
Q3
$1.08M Sell
3,118
-33
-1% -$11.5K 0.05% 264
2023
Q2
$1.11M Sell
3,151
-208
-6% -$73.2K 0.05% 267
2023
Q1
$1.06M Sell
3,359
-91
-3% -$28.7K 0.05% 279
2022
Q4
$996K Buy
3,450
+91
+3% +$26.3K 0.05% 276
2022
Q3
$973K Buy
3,359
+156
+5% +$45.2K 0.06% 242
2022
Q2
$903K Sell
3,203
-281
-8% -$79.2K 0.05% 221
2022
Q1
$909K Sell
3,484
-141
-4% -$36.8K 0.06% 210
2021
Q4
$796K Buy
3,625
+2,185
+152% +$480K 0.05% 232
2021
Q3
$261K Buy
1,440
+6
+0.4% +$1.09K 0.02% 455
2021
Q2
$289K Buy
1,434
+33
+2% +$6.65K 0.02% 436
2021
Q1
$301K Buy
+1,401
New +$301K 0.02% 395
2020
Q2
Sell
-107
Closed -$25K 1336
2020
Q1
$25K Buy
107
+4
+4% +$935 ﹤0.01% 680
2019
Q4
$23K Hold
103
﹤0.01% 736
2019
Q3
$17K Hold
103
﹤0.01% 797
2019
Q2
$19K Hold
103
﹤0.01% 739
2019
Q1
$19K Hold
103
﹤0.01% 677
2018
Q4
$17K Hold
103
﹤0.01% 669
2018
Q3
$20K Hold
103
﹤0.01% 679
2018
Q2
$18K Hold
103
﹤0.01% 702
2018
Q1
$17K Sell
103
-3
-3% -$495 ﹤0.01% 626
2017
Q4
$16K Buy
106
+3
+3% +$453 ﹤0.01% 581
2017
Q3
$16K Buy
+103
New +$16K ﹤0.01% 466